Phreesia vs McKesson

Side-by-side comparison of AI visibility scores, market position, and capabilities

McKesson leads in AI visibility (79 vs 40)
Phreesia logo

Phreesia

EmergingHealthcare

Patient Intake

NYSE-listed (PHR) patient intake platform digitizing check-in for 4,000+ practices at $383M revenue; pharma-funded activation programs competing with Epic and Clearwave for healthcare front-office engagement.

AI VisibilityBeta
Overall Score
C40
Category Rank
#379 of 596
AI Consensus
78%
Trend
up
Per Platform
ChatGPT
38
Perplexity
35
Gemini
44

About

Phreesia is a Raleigh, North Carolina-based patient intake and engagement platform — listed on NYSE (NYSE: PHR) — providing healthcare practices, health systems, and pharmaceutical companies with digital tools for patient registration, insurance verification, payment collection, clinical pre-screening, and patient activation. Founded in 2005 by Chaim Indig and Evan Roberts and generating $383 million in revenue in fiscal year 2025 (ending January 2025), Phreesia serves 4,000+ healthcare practices and health systems with the patient-facing digital infrastructure that replaces paper clipboards and manual front-desk registration.

Full profile
McKesson logo

McKesson

LeaderHealthcare

General

Largest US pharmaceutical distributor with $308.9B FY2024 revenue; thin-margin distribution triopoly with Cencora and Cardinal Health; US Oncology Network (1,700+ oncologists) is highest-margin segment.

AI VisibilityBeta
Overall Score
B79
Category Rank
#26 of 596
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
82
Perplexity
76
Gemini
82

About

McKesson Corporation is the largest pharmaceutical distributor in North America and a leading healthcare services company, founded in 1833 in New York City by John McKesson and Charles Olcott and now headquartered in Irving, Texas, trading on NYSE (MCK). The company reported approximately $308.9 billion in revenues for fiscal year 2024 (ending March 31, 2024) under CEO Brian Tyler, making it one of the highest-revenue companies in the United States—though the vast majority of revenues represent pass-through pharmaceutical product costs distributed to approximately 40,000 pharmacies, health systems, and medical providers across North America. McKesson operates through four segments: U.S. Pharmaceutical (the dominant distribution engine), Prescription Technology Solutions (pharmacy benefits technology including CoverMyMeds e-prior authorization), Medical-Surgical Solutions (physician office and extended care medical supply distribution), and International (primarily Canadian distribution through McKesson Canada).

Full profile

AI Visibility Head-to-Head

40
Overall Score
79
#379
Category Rank
#26
78
AI Consensus
77
up
Trend
stable
38
ChatGPT
82
35
Perplexity
76
44
Gemini
82
42
Claude
85
38
Grok
77

Key Details

Category
Patient Intake
General
Tier
Emerging
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Phreesia
Patient Intake
Phreesia is classified as company. McKesson is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.